Consuelo Soldevila-Pico

University of Florida, USA

Articles in Scholarly Journals [Incomplete List]

  1. Factors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years' Experience from a Single Tertiary Medical Center
    Journal of Vascular and Interventional Radiology, vol. 19, no. 11, pp. 1576–1581, 2008
  2. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma
    Liver Transplantation, vol. 13, no. 3, pp. 334–342, 2007
  3. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation
    Liver Transplantation, vol. 13, no. 8, pp. 1137–1144, 2007
  4. Prevalence and Predictors of Esophageal Varices in Patients With Primary Biliary Cirrhosis
    Clinical Gastroenterology and Hepatology, vol. 5, no. 7, pp. 803–808, 2007
  5. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation
    Liver Transplantation, vol. 12, no. 5, pp. 754–761, 2006
  6. Betaine Resolves Severe Alcohol-Induced Hepatitis and Steatosis Following Liver Transplantation
    Digestive Diseases and Sciences, vol. 51, no. 7, pp. 1226–1229, 2006
  7. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
    Liver Transplantation, vol. 12, no. 1, pp. 51–57, 2005
  8. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease
    Liver Transplantation, vol. 12, no. 1, pp. 124–133, 2005
  9. Short Recovery Time After Percutaneous Liver Biopsy: Should We Change Our Current Practices?
    Clinical Gastroenterology and Hepatology, vol. 3, no. 9, pp. 926–929, 2005
  10. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
    Liver Transplantation, vol. 10, no. 2, pp. 199–207, 2004
  11. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
    Liver Transplantation, vol. 10, no. 10, pp. 1240–1247, 2004
  12. Prevalence of HBV precore/core promoter variants in the United States
    Hepatology, vol. 38, no. 3, pp. 619–628, 2003
  13. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect
    Hepatology, vol. 38, no. 4, pp. 859–868, 2003
  14. Hepatitis B virus genotypes in the United States: results of a nationwide study
    Gastroenterology, vol. 125, no. 2, pp. 444–451, 2003
  15. Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B
    Liver Transplantation, vol. 8, no. 5, pp. 433–439, 2002
  16. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Liver Transplantation, vol. 8, no. 11, pp. 1000–1006, 2002
  17. Anti[ndash ]Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation
    Liver Transplantation, vol. 7, no. 12, pp. 1064–1070, 2001
  18. Epidemiology and serologic diagnosis of hepatitis E
    Journal of Hepatology, vol. 20, no. 5, pp. 567–569, 1994
  19. Pseudopolyposis medicamentosus
    Gastrointestinal Endoscopy, vol. 39, no. 2, pp. 213–214, 1993